{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:31:57Z","timestamp":1791775917027,"version":"4.3.4"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1038\/onc.2009.351","type":"journal-article","created":{"date-parts":[[2009,12,3]],"date-time":"2009-12-03T08:57:10Z","timestamp":1259830630000},"page":"S31-S42","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":158,"title":["Human tumor-associated viruses and new insights into the molecular mechanisms of cancer"],"prefix":"10.1038","volume":"27","author":[{"given":"D","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J S","family":"Gutkind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,3]]},"reference":[{"key":"BFonc2009351_CR1","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1182\/blood.V93.12.4034.412k38_4034_4043","volume":"93","author":"Y Aoki","year":"1999","unstructured":"Aoki Y, Jaffe ES, Chang Y, Jones K, Teruya-Feldstein J, Moore PS et al. (1999). Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93: 4034\u20134043.","journal-title":"Blood"},{"key":"BFonc2009351_CR2","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/S1474-4422(06)70628-7","volume":"5","author":"AQ Araujo","year":"2006","unstructured":"Araujo AQ, Silva MT . (2006). The HTLV-1 neurological complex. Lancet Neurol 5: 1068\u20131076.","journal-title":"Lancet Neurol"},{"key":"BFonc2009351_CR3","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4049\/jimmunol.155.3.1047","volume":"155","author":"L Arvanitakis","year":"1995","unstructured":"Arvanitakis L, Yaseen N, Sharma S . (1995). Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells. J Immunol 155: 1047\u20131056.","journal-title":"J Immunol"},{"key":"BFonc2009351_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/385347a0","volume":"385","author":"L Arvanitakis","year":"1997","unstructured":"Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E . (1997). Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385: 347\u2013350.","journal-title":"Nature"},{"key":"BFonc2009351_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/34193","volume":"391","author":"C Bais","year":"1998","unstructured":"Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS et al. (1998). G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391: 86\u201389.","journal-title":"Nature"},{"key":"BFonc2009351_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S1535-6108(03)00024-2","volume":"3","author":"C Bais","year":"2003","unstructured":"Bais C, Van Geelen A, Eroles P, Mutlu A, Chiozzini C, Dias S et al. (2003). Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2\/KDR. Cancer Cell 3: 131\u2013143.","journal-title":"Cancer Cell"},{"key":"BFonc2009351_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/321246a0","volume":"321","author":"S Beaudenon","year":"1986","unstructured":"Beaudenon S, Kremsdorf D, Croissant O, Jablonska S, Wain-Hobson S, Orth G . (1986). A novel type of human papillomavirus associated with genital neoplasias. Nature 321: 246\u2013249.","journal-title":"Nature"},{"key":"BFonc2009351_CR8","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.1128\/JVI.74.11.5024-5031.2000","volume":"74","author":"DS Bellows","year":"2000","unstructured":"Bellows DS, Chau BN, Lee P, Lazebnik Y, Burns WH, Hardwick JM . (2000). Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins. J Virol 74: 5024\u20135031.","journal-title":"J Virol"},{"key":"BFonc2009351_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1126\/science.325649","volume":"197","author":"BS Blumberg","year":"1977","unstructured":"Blumberg BS . (1977). Australia antigen and the biology of hepatitis B. Science 197: 17\u201325.","journal-title":"Science"},{"key":"BFonc2009351_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/01.qco.0000200295.30285.13","volume":"19","author":"M Bower","year":"2006","unstructured":"Bower M, Palmieri C, Dhillon T . (2006). AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis 19: 14\u201319.","journal-title":"Curr Opin Infect Dis"},{"key":"BFonc2009351_CR11","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1084\/jem.193.8.943","volume":"193","author":"KD Brown","year":"2001","unstructured":"Brown KD, Hostager BS, Bishop GA . (2001). Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J Exp Med 193: 943\u2013954.","journal-title":"J Exp Med"},{"key":"BFonc2009351_CR12","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1038\/sj.onc.1210299","volume":"26","author":"D Bubman","year":"2007","unstructured":"Bubman D, Guasparri I, Cesarman E . (2007). Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen. Oncogene 26: 4979\u20134986.","journal-title":"Oncogene"},{"key":"BFonc2009351_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/194232a0","volume":"194","author":"D Burkitt","year":"1962","unstructured":"Burkitt D . (1962). A children's cancer dependent on climatic factors. Nature 194: 232\u2013234.","journal-title":"Nature"},{"key":"BFonc2009351_CR14","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1001\/jama.1976.03260520026017","volume":"235","author":"EB Buynak","year":"1976","unstructured":"Buynak EB, Roehm RR, Tytell AA, Bertland II AU, Lampson GP, Hilleman MR . (1976). Vaccine against human hepatitis B. JAMA 235: 2832\u20132834.","journal-title":"JAMA"},{"key":"BFonc2009351_CR15","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1073\/pnas.0408192102","volume":"102","author":"X Cai","year":"2005","unstructured":"Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR . (2005). Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci USA 102: 5570\u20135575.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009351_CR16","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","volume":"332","author":"E Cesarman","year":"1995","unstructured":"Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM . (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332: 1186\u20131191.","journal-title":"N Engl J Med"},{"key":"BFonc2009351_CR17","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1126\/science.7997879","volume":"266","author":"Y Chang","year":"1994","unstructured":"Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM et al. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865\u20131869.","journal-title":"Science"},{"key":"BFonc2009351_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.immunol.16.1.395","volume":"16","author":"DT Chao","year":"1998","unstructured":"Chao DT, Korsmeyer SJ . (1998). BCL-2 family: regulators of cell death. Annu Rev Immunol 16: 395\u2013419.","journal-title":"Annu Rev Immunol"},{"key":"BFonc2009351_CR19","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1126\/science.1074883","volume":"298","author":"M Chatterjee","year":"2002","unstructured":"Chatterjee M, Osborne J, Bestetti G, Chang Y, Moore PS . (2002). Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298: 1432\u20131435.","journal-title":"Science"},{"key":"BFonc2009351_CR20","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1200\/JCO.2007.14.1713","volume":"26","author":"AK Chaturvedi","year":"2008","unstructured":"Chaturvedi AK, Engels EA, Anderson WF, Gillison ML . (2008). Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26: 612\u2013619.","journal-title":"J Clin Oncol"},{"key":"BFonc2009351_CR21","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1128\/JVI.76.7.3421-3439.2002","volume":"76","author":"CJ Chiou","year":"2002","unstructured":"Chiou CJ, Poole LJ, Kim PS, Ciufo DM, Cannon JS, ap Rhys CM et al. (2002). Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. J Virol 76: 3421\u20133439.","journal-title":"J Virol"},{"key":"BFonc2009351_CR22","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.1128\/JVI.02396-07","volume":"82","author":"YB Choi","year":"2008","unstructured":"Choi YB, Nicholas J . (2008). Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines. J Virol 82: 6501\u20136513.","journal-title":"J Virol"},{"key":"BFonc2009351_CR23","first-page":"12","volume":"48","author":"G Ciuffo","year":"1907","unstructured":"Ciuffo G . (1907). Innesto positivo con filtrato di verruca volgare. G Ital d mal ven ed pelle 48: 12.","journal-title":"G Ital d mal ven ed pelle"},{"key":"BFonc2009351_CR24","volume-title":"Retroviruses","author":"JM Coffin","year":"1997","unstructured":"Coffin JM, Hughes SH, Varmus H . (1997). Retroviruses. Cold Spring Harbor Laboratory Press: Plainview, NY."},{"key":"BFonc2009351_CR25","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S0140-6736(89)91016-7","volume":"2","author":"M Colombo","year":"1989","unstructured":"Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA et al. (1989). Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 2: 1006\u20131008.","journal-title":"Lancet"},{"key":"BFonc2009351_CR26","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1006\/viro.1999.9999","volume":"264","author":"MA Cotter II","year":"1999","unstructured":"Cotter II MA, Robertson ES . (1999). The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264: 254\u2013264.","journal-title":"Virology"},{"key":"BFonc2009351_CR27","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/S0140-6736(77)91996-1","volume":"1","author":"JL Dienstag","year":"1977","unstructured":"Dienstag JL, Purcell HR, Alter HJ, Feinstone SM, Wong DC, Holland PV . (1977). Non-A, non-B post-transfusion hepatitis. Lancet 1: 560\u2013562.","journal-title":"Lancet"},{"key":"BFonc2009351_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/(SICI)1521-1878(199805)20:5<367::AID-BIES3>3.0.CO;2-L","volume":"20","author":"D Dittmer","year":"1998","unstructured":"Dittmer D, Kedes DH . (1998). Do viral chemokines modulate Kaposi's sarcoma? Bioessays 20: 367\u2013370.","journal-title":"Bioessays"},{"key":"BFonc2009351_CR29","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.1128\/JVI.72.10.8309-8315.1998","volume":"72","author":"D Dittmer","year":"1998","unstructured":"Dittmer D, Lagunoff M, Renne R, Staskus K, Haase A, Ganem D . (1998). A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol 72: 8309\u20138315.","journal-title":"J Virol"},{"key":"BFonc2009351_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrc2069","volume":"7","author":"RT Dorsam","year":"2007","unstructured":"Dorsam RT, Gutkind JS . (2007). G-protein-coupled receptors and cancer. Nat Rev Cancer 7: 79\u201394.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2009351_CR31","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1073\/pnas.67.4.1673","volume":"67","author":"PH Duesberg","year":"1970","unstructured":"Duesberg PH, Vogt PK . (1970). Differences between the ribonucleic acids of transforming and non-transforming avian tumor viruses. Proc Natl Acad Sci USA 67: 1673\u20131680.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009351_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0092-8674(89)90839-8","volume":"58","author":"N Dyson","year":"1989","unstructured":"Dyson N, Buchkovich K, Whyte P, Harlow E . (1989a). The cellular 107 K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 58: 249\u2013255.","journal-title":"Cell"},{"key":"BFonc2009351_CR33","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1126\/science.2537532","volume":"243","author":"N Dyson","year":"1989","unstructured":"Dyson N, Howley PM, Munger K, Harlow E . (1989b). The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934\u2013937.","journal-title":"Science"},{"key":"BFonc2009351_CR34","first-page":"595","volume":"46","author":"V Ellermann","year":"1908","unstructured":"Ellermann V, Bang O . (1908). Experimentelle leukamie bei huhnern. Zentralbl Bakteriol Parasitenkd Infektionskr Hyg 46: 595\u2013597.","journal-title":"Zentralbl Bakteriol Parasitenkd Infektionskr Hyg"},{"key":"BFonc2009351_CR35","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/emboj\/18.3.644","volume":"18","author":"M Ellis","year":"1999","unstructured":"Ellis M, Chew YP, Fallis L, Freddersdorf S, Boshoff C, Weiss RA et al. (1999). Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. EMBO J 18: 644\u2013653.","journal-title":"EMBO J"},{"key":"BFonc2009351_CR36","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1084\/jem.121.5.761","volume":"121","author":"MA Epstein","year":"1965","unstructured":"Epstein MA, Henle G, Achong BG, Barr YM . (1965). Morphological and biological studies on a virus in cultured lymphoblasts from Burkitt's lymphoma. J Exp Med 121: 761\u2013770.","journal-title":"J Exp Med"},{"key":"BFonc2009351_CR37","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/S0140-6736(71)91898-8","volume":"1","author":"MA Epstein","year":"1971","unstructured":"Epstein MA . (1971). The possible role of viruses in human cancer. Lancet 1: 1344\u20131347.","journal-title":"Lancet"},{"key":"BFonc2009351_CR38","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1098\/rstb.2000.0774","volume":"356","author":"MA Epstein","year":"2001","unstructured":"Epstein MA . (2001). Historical background. Philos Trans R Soc Lond B Biol Sci 356: 413\u2013420.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"BFonc2009351_CR39","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1242\/jcs.00691","volume":"116","author":"N Field","year":"2003","unstructured":"Field N, Low W, Daniels M, Howell S, Daviet L, Boshoff C et al. (2003). KSHV vFLIP binds to IKK-gamma to activate IKK. J Cell Sci 116: 3721\u20133728.","journal-title":"J Cell Sci"},{"key":"BFonc2009351_CR40","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/323643a0","volume":"323","author":"SH Friend","year":"1986","unstructured":"Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM et al. (1986). A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643\u2013646.","journal-title":"Nature"},{"key":"BFonc2009351_CR41","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nm829","volume":"9","author":"M Fujimuro","year":"2003","unstructured":"Fujimuro M, Wu FY, ApRhys C, Kajumbula H, Young DB, Hayward GS et al. (2003). A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat Med 9: 300\u2013306.","journal-title":"Nat Med"},{"key":"BFonc2009351_CR42","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra031087","volume":"350","author":"D Ganem","year":"2004","unstructured":"Ganem D, Prince AM . (2004). Hepatitis B virus infection--natural history and clinical consequences. N Engl J Med 350: 1118\u20131129.","journal-title":"N Engl J Med"},{"key":"BFonc2009351_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev.pathol.1.110304.100133","volume":"1","author":"D Ganem","year":"2006","unstructured":"Ganem D . (2006). KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol 1: 273\u2013296.","journal-title":"Annu Rev Pathol"},{"key":"BFonc2009351_CR44","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1038\/sj.onc.1201571","volume":"15","author":"SJ Gao","year":"1997","unstructured":"Gao SJ, Boshoff C, Jayachandra S, Weiss RA, Chang Y, Moore PS . (1997). KSHV ORF K9 (vIRF) is an oncogene, which inhibits the interferon signaling pathway. Oncogene 15: 1979\u20131985.","journal-title":"Oncogene"},{"key":"BFonc2009351_CR45","doi-asserted-by":"publisher","first-page":"A4","DOI":"10.1016\/j.vaccine.2008.11.069","volume":"27","author":"R Gasparini","year":"2009","unstructured":"Gasparini R, Panatto D . (2009). Cervical cancer: From Hippocrates through Rigoni-Stern to zur Hausen. Vaccine 27: A4\u2013A5.","journal-title":"Vaccine"},{"key":"BFonc2009351_CR46","first-page":"59","volume":"39","author":"CC Geilen","year":"2006","unstructured":"Geilen CC, Husak R, Steinhoff M . (2006). Pathogenesis and clinical manifestation of Kaposi's sarcoma. Front Radiat Ther Oncol 39: 59\u201367.","journal-title":"Front Radiat Ther Oncol"},{"key":"BFonc2009351_CR47","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1172\/JCI4461","volume":"102","author":"MC Gershengorn","year":"1998","unstructured":"Gershengorn MC, Geras-Raaka E, Varma A, Clark-Lewis I . (1998). Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. J Clin Invest 102: 1469\u20131472.","journal-title":"J Clin Invest"},{"key":"BFonc2009351_CR48","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1172\/JCI26666","volume":"116","author":"MG Grisotto","year":"2006","unstructured":"Grisotto MG, Garin A, Martin AP, Jensen KK, Chan P, Sealfon SC et al. (2006). The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells. J Clin Invest 116: 1264\u20131273.","journal-title":"J Clin Invest"},{"key":"BFonc2009351_CR49","doi-asserted-by":"publisher","first-page":"7179","DOI":"10.1128\/JVI.01603-05","volume":"80","author":"C Grossmann","year":"2006","unstructured":"Grossmann C, Podgrabinska S, Skobe M, Ganem D . (2006). Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype. J Virol 80: 7179\u20137185.","journal-title":"J Virol"},{"key":"BFonc2009351_CR50","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1126\/science.284.5415.825","volume":"284","author":"LG Guidotti","year":"1999","unstructured":"Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV . (1999). Viral clearance without destruction of infected cells during acute HBV infection. Science 284: 825\u2013829.","journal-title":"Science"},{"key":"BFonc2009351_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev.pathol.1.110304.100230","volume":"1","author":"LG Guidotti","year":"2006","unstructured":"Guidotti LG, Chisari FV . (2006). Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 1: 23\u201361.","journal-title":"Annu Rev Pathol"},{"key":"BFonc2009351_CR52","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0959-437X(01)00265-9","volume":"12","author":"ES Hickman","year":"2002","unstructured":"Hickman ES, Moroni MC, Helin K . (2002). The role of p53 and pRB in apoptosis and cancer. Curr Opin Genet Dev 12: 60\u201366.","journal-title":"Curr Opin Genet Dev"},{"key":"BFonc2009351_CR53","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1001\/jama.1969.03160090027006","volume":"208","author":"RJ Hirschman","year":"1969","unstructured":"Hirschman RJ, Shulman NR, Barker LF, Smith KO . (1969). Virus-like particles in sera of patients with infectious and serum hepatitis. JAMA 208: 1667\u20131670.","journal-title":"JAMA"},{"key":"BFonc2009351_CR54","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.virol.2008.12.006","volume":"384","author":"PM Howley","year":"2009","unstructured":"Howley PM, Livingston DM . (2009). Small DNA tumor viruses: large contributors to biomedical sciences. Virology 384: 256\u2013259.","journal-title":"Virology"},{"key":"BFonc2009351_CR55","doi-asserted-by":"publisher","first-page":"11677","DOI":"10.1128\/JVI.76.22.11677-11687.2002","volume":"76","author":"J Hu","year":"2002","unstructured":"Hu J, Garber AC, Renne R . (2002). The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J Virol 76: 11677\u201311687.","journal-title":"J Virol"},{"key":"BFonc2009351_CR56","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/40657","volume":"388","author":"M Irmler","year":"1997","unstructured":"Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V et al. (1997). Inhibition of death receptor signals by cellular FLIP. Nature 388: 190\u2013195.","journal-title":"Nature"},{"key":"BFonc2009351_CR57","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.1158\/0008-5472.CAN-08-3301","volume":"68","author":"RT Javier","year":"2008","unstructured":"Javier RT, Butel JS . (2008). The history of tumor virology. Cancer Res 68: 7693\u20137706.","journal-title":"Cancer Res"},{"key":"BFonc2009351_CR58","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.4049\/jimmunol.174.6.3686","volume":"174","author":"KK Jensen","year":"2005","unstructured":"Jensen KK, Manfra DJ, Grisotto MG, Martin AP, Vassileva G, Kelley K et al. (2005). The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma. J Immunol 174: 3686\u20133694.","journal-title":"J Immunol"},{"key":"BFonc2009351_CR59","doi-asserted-by":"publisher","first-page":"e1000397","DOI":"10.1371\/journal.ppat.1000397","volume":"5","author":"M Kadaja","year":"2009","unstructured":"Kadaja M, Isok-Paas H, Laos T, Ustav E, Ustav M . (2009). Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog 5: e1000397.","journal-title":"PLoS Pathog"},{"key":"BFonc2009351_CR60","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1473-3099(02)00315-8","volume":"2","author":"JH Kao","year":"2002","unstructured":"Kao JH, Chen DS . (2002). Global control of hepatitis B virus infection. Lancet Infect Dis 2: 395\u2013403.","journal-title":"Lancet Infect Dis"},{"key":"BFonc2009351_CR61","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1182\/blood.V96.7.2537.h8002537_2537_2542","volume":"96","author":"SA Keller","year":"2000","unstructured":"Keller SA, Schattner EJ, Cesarman E . (2000). Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 96: 2537\u20132542.","journal-title":"Blood"},{"key":"BFonc2009351_CR62","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/emboj\/17.6.1700","volume":"17","author":"E Kilger","year":"1998","unstructured":"Kilger E, Kieser A, Baumann M, Hammerschmidt W . (1998). Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J 17: 1700\u20131709.","journal-title":"EMBO J"},{"key":"BFonc2009351_CR63","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson Jr","year":"1971","unstructured":"Knudson Jr AG . (1971). Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820\u2013823.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009351_CR64","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0764-4469(01)01368-3","volume":"324","author":"H Lecoq","year":"2001","unstructured":"Lecoq H . (2001). Discovery of the first virus, the tobacco mosaic virus: 1892 or 1898? C R Acad Sci III 324: 929\u2013933.","journal-title":"C R Acad Sci III"},{"key":"BFonc2009351_CR65","doi-asserted-by":"publisher","first-page":"586","DOI":"10.7547\/0950586","volume":"95","author":"MJ Levi","year":"2005","unstructured":"Levi MJ . (2005). Classic Kaposi's sarcoma. J Am Podiatr Med Assoc 95: 586\u2013588.","journal-title":"J Am Podiatr Med Assoc"},{"key":"BFonc2009351_CR66","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","volume":"88","author":"AJ Levine","year":"1997","unstructured":"Levine AJ . (1997). p53, the cellular gatekeeper for growth and division. Cell 88: 323\u2013331.","journal-title":"Cell"},{"key":"BFonc2009351_CR67","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0092-8674(87)90556-3","volume":"49","author":"L Lombardi","year":"1987","unstructured":"Lombardi L, Newcomb EW, Dalla-Favera R . (1987). Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell 49: 161\u2013170.","journal-title":"Cell"},{"key":"BFonc2009351_CR68","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/immu.200310025","volume":"33","author":"J Louahed","year":"2003","unstructured":"Louahed J, Struyf S, Demoulin JB, Parmentier M, Van Snick J, Van Damme J et al. (2003). CCR8-dependent activation of the RAS\/MAPK pathway mediates anti-apoptotic activity of I-309\/CCL1 and vMIP-I. Eur J Immunol 33: 494\u2013501.","journal-title":"Eur J Immunol"},{"key":"BFonc2009351_CR69","doi-asserted-by":"publisher","first-page":"7874","DOI":"10.1038\/sj.onc.1204869","volume":"20","author":"F Mantovani","year":"2001","unstructured":"Mantovani F, Banks L . (2001). The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20: 7874\u20137887.","journal-title":"Oncogene"},{"key":"BFonc2009351_CR70","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1038\/sj.onc.1210817","volume":"27","author":"D Martin","year":"2008","unstructured":"Martin D, Galisteo R, Ji Y, Montaner S, Gutkind JS . (2008). An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia. Oncogene 27: 1844\u20131852.","journal-title":"Oncogene"},{"key":"BFonc2009351_CR71","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrc2111","volume":"7","author":"M Matsuoka","year":"2007","unstructured":"Matsuoka M, Jeang KT . (2007). Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 7: 270\u2013280.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2009351_CR72","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1126\/science.1105779","volume":"307","author":"C McCormick","year":"2005","unstructured":"McCormick C, Ganem D . (2005). The kaposin B protein of KSHV activates the p38\/MK2 pathway and stabilizes cytokine mRNAs. Science 307: 739\u2013741.","journal-title":"Science"},{"key":"BFonc2009351_CR73","doi-asserted-by":"publisher","first-page":"19625","DOI":"10.1074\/jbc.272.31.19625","volume":"272","author":"J Molden","year":"1997","unstructured":"Molden J, Chang Y, You Y, Moore PS, Goldsmith MA . (1997). A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem 272: 19625\u201319631.","journal-title":"J Biol Chem"},{"key":"BFonc2009351_CR74","first-page":"2641","volume":"61","author":"S Montaner","year":"2001","unstructured":"Montaner S, Sodhi A, Pece S, Mesri EA, Gutkind JS . (2001). The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt\/protein kinase B. Cancer Res 61: 2641\u20132648.","journal-title":"Cancer Res"},{"key":"BFonc2009351_CR75","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1535-6108(02)00237-4","volume":"3","author":"S Montaner","year":"2003","unstructured":"Montaner S, Sodhi A, Molinolo A, Bugge TH, Sawai ET, He Y et al. (2003). Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3: 23\u201336.","journal-title":"Cancer Cell"},{"key":"BFonc2009351_CR76","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1182\/blood-2003-12-4436","volume":"104","author":"S Montaner","year":"2004","unstructured":"Montaner S, Sodhi A, Servitja JM, Ramsdell AK, Barac A, Sawai ET et al. (2004). The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia. Blood 104: 2903\u20132911.","journal-title":"Blood"},{"key":"BFonc2009351_CR77","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1158\/0008-5472.CAN-05-1026","volume":"66","author":"S Montaner","year":"2006","unstructured":"Montaner S, Sodhi A, Ramsdell AK, Martin D, Hu J, Sawai ET et al. (2006). The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. Cancer Res 66: 168\u2013174.","journal-title":"Cancer Res"},{"key":"BFonc2009351_CR78","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0092-8674(95)90489-1","volume":"80","author":"G Mosialos","year":"1995","unstructured":"Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E . (1995). The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80: 389\u2013399.","journal-title":"Cell"},{"key":"BFonc2009351_CR79","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1084\/jem.188.2.341","volume":"188","author":"Y Nakamoto","year":"1998","unstructured":"Nakamoto Y, Guidotti LG, Kuhlen CV, Fowler P, Chisari FV . (1998). Immune pathogenesis of hepatocellular carcinoma. J Exp Med 188: 341\u2013350.","journal-title":"J Exp Med"},{"key":"BFonc2009351_CR80","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nm0397-287","volume":"3","author":"J Nicholas","year":"1997","unstructured":"Nicholas J, Ruvolo VR, Burns WH, Sandford G, Wan X, Ciufo D et al. (1997). Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med 3: 287\u2013292.","journal-title":"Nat Med"},{"key":"BFonc2009351_CR81","first-page":"185","volume":"312","author":"MK Offermann","year":"2007","unstructured":"Offermann MK . (2007). Kaposi sarcoma herpesvirus-encoded interferon regulator factors. Curr Top Microbiol Immunol 312: 185\u2013209.","journal-title":"Curr Top Microbiol Immunol"},{"key":"BFonc2009351_CR82","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1002\/ijc.21731","volume":"118","author":"DM Parkin","year":"2006","unstructured":"Parkin DM . (2006). The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118: 3030\u20133044.","journal-title":"Int J Cancer"},{"key":"BFonc2009351_CR83","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1056\/NEJM200011093431904","volume":"343","author":"J Pauk","year":"2000","unstructured":"Pauk J, Huang ML, Brodie SJ, Wald A, Koelle DM, Schacker T et al. (2000). Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 343: 1369\u20131377.","journal-title":"N Engl J Med"},{"key":"BFonc2009351_CR84","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC . (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77: 7415\u20137419.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009351_CR85","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/80459","volume":"6","author":"SA Radkov","year":"2000","unstructured":"Radkov SA, Kellam P, Boshoff C . (2000). The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 6: 1121\u20131127.","journal-title":"Nat Med"},{"key":"BFonc2009351_CR86","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.1128\/jvi.71.8.5915-5921.1997","volume":"71","author":"L Rainbow","year":"1997","unstructured":"Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, Stoiber H et al. (1997). The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 71: 5915\u20135921.","journal-title":"J Virol"},{"key":"BFonc2009351_CR87","doi-asserted-by":"publisher","first-page":"26309","DOI":"10.1074\/jbc.M003800200","volume":"275","author":"MM Rosenkilde","year":"2000","unstructured":"Rosenkilde MM, Kledal TN, Holst PJ, Schwartz TW . (2000). Selective elimination of high constitutive activity or chemokine binding in the human herpesvirus 8 encoded seven transmembrane oncogene ORF74. J Biol Chem 275: 26309\u201326315.","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"BFonc2009351_CR88","doi-asserted-by":"publisher","first-page":"S154","DOI":"10.1038\/sj.bjp.0707660","volume":"153","author":"MM Rosenkilde","year":"2008","unstructured":"Rosenkilde MM, Smit MJ, Waldhoer M . (2008). Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptors. Br J Pharmacol 153 Suppl 1: S154\u2013S166.","journal-title":"Br J Pharmacol"},{"key":"BFonc2009351_CR89","doi-asserted-by":"crossref","unstructured":"Rous P . (1910). A transmissible avian neoplasm (sarcoma of the common fowl). pp 696\u2013705.","DOI":"10.1084\/jem.12.5.696"},{"key":"BFonc2009351_CR90","doi-asserted-by":"crossref","unstructured":"Rous P . (1911). A sarcoma of the fowl transmissible by an agent separable from the tumor cells. pp 397\u2013411.","DOI":"10.1084\/jem.13.4.397"},{"key":"BFonc2009351_CR91","doi-asserted-by":"publisher","first-page":"14862","DOI":"10.1073\/pnas.93.25.14862","volume":"93","author":"JJ Russo","year":"1996","unstructured":"Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D et al. (1996). Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 93: 14862\u201314867.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009351_CR92","first-page":"7","volume":"14","author":"B Safai","year":"1987","unstructured":"Safai B . (1987). Pathophysiology and epidemiology of epidemic Kaposi's sarcoma. Semin Oncol 14: 7\u201312.","journal-title":"Semin Oncol"},{"key":"BFonc2009351_CR93","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nm0397-293","volume":"3","author":"R Sarid","year":"1997","unstructured":"Sarid R, Sato T, Bohenzky RA, Russo JJ, Chang Y . (1997). Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med 3: 293\u2013298.","journal-title":"Nat Med"},{"key":"BFonc2009351_CR94","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","volume":"63","author":"M Scheffner","year":"1990","unstructured":"Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM . (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129\u20131136.","journal-title":"Cell"},{"key":"BFonc2009351_CR95","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0092-8674(93)90384-3","volume":"75","author":"M Scheffner","year":"1993","unstructured":"Scheffner M, Huibregtse JM, Vierstra RD, Howley PM . (1993). The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495\u2013505.","journal-title":"Cell"},{"key":"BFonc2009351_CR96","doi-asserted-by":"publisher","first-page":"8797","DOI":"10.1128\/JVI.76.17.8797-8807.2002","volume":"76","author":"T Seo","year":"2002","unstructured":"Seo T, Lee D, Shim YS, Angell JE, Chidambaram NV, Kalvakolanu DV et al. (2002). Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon\/retinoic acid-induced cell death. J Virol 76: 8797\u20138807.","journal-title":"J Virol"},{"key":"BFonc2009351_CR97","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/15216540050022395","volume":"49","author":"TV Sharp","year":"2000","unstructured":"Sharp TV, Boshoff C . (2000). Kaposi's sarcoma-associated herpesvirus: from cell biology to pathogenesis. IUBMB Life 49: 97\u2013104.","journal-title":"IUBMB Life"},{"key":"BFonc2009351_CR98","first-page":"4873","volume":"60","author":"A Sodhi","year":"2000","unstructured":"Sodhi A, Montaner S, Patel V, Zohar M, Bais C, Mesri EA et al. (2000). The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res 60: 4873\u20134880.","journal-title":"Cancer Res"},{"key":"BFonc2009351_CR99","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1006\/bbrc.2001.5532","volume":"287","author":"A Sodhi","year":"2001","unstructured":"Sodhi A, Montaner S, Miyazaki H, Gutkind JS . (2001). MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF. Biochem Biophys Res Commun 287: 292\u2013300.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2009351_CR100","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1096\/fj.03-1035hyp","volume":"18","author":"A Sodhi","year":"2004","unstructured":"Sodhi A, Montaner S, Gutkind JS . (2004a). Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis? FASEB J 18: 422\u2013427.","journal-title":"FASEB J"},{"key":"BFonc2009351_CR101","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1073\/pnas.0400835101","volume":"101","author":"A Sodhi","year":"2004","unstructured":"Sodhi A, Montaner S, Patel V, Gomez-Roman JJ, Li Y, Sausville EA et al. (2004b). Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor. Proc Natl Acad Sci USA 101: 4821\u20134826.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009351_CR102","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ccr.2006.05.026","volume":"10","author":"A Sodhi","year":"2006","unstructured":"Sodhi A, Chaisuparat R, Hu J, Ramsdell AK, Manning BD, Sausville EA et al. (2006). The TSC2\/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Cancer Cell 10: 133\u2013143.","journal-title":"Cancer Cell"},{"key":"BFonc2009351_CR103","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa042831","volume":"352","author":"G Stallone","year":"2005","unstructured":"Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G et al. (2005). Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 352: 1317\u20131323.","journal-title":"N Engl J Med"},{"key":"BFonc2009351_CR104","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1128\/JVI.73.5.4181-4187.1999","volume":"73","author":"KA Staskus","year":"1999","unstructured":"Staskus KA, Sun R, Miller G, Racz P, Jaslowski A, Metroka C et al. (1999). Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol 73: 4181\u20134187.","journal-title":"J Virol"},{"key":"BFonc2009351_CR105","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/260170a0","volume":"260","author":"D Stehelin","year":"1976","unstructured":"Stehelin D, Varmus HE, Bishop JM, Vogt PK . (1976). DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260: 170\u2013173.","journal-title":"Nature"},{"key":"BFonc2009351_CR106","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1349-7006.2006.00299.x","volume":"97","author":"H Tang","year":"2006","unstructured":"Tang H, Oishi N, Kaneko S, Murakami S . (2006). Molecular functions and biological roles of hepatitis B virus x protein. Cancer Sci 97: 977\u2013983.","journal-title":"Cancer Sci"},{"key":"BFonc2009351_CR107","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/jama.284.4.450","volume":"284","author":"DL Thomas","year":"2000","unstructured":"Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N et al. (2000). The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284: 450\u2013456.","journal-title":"JAMA"},{"key":"BFonc2009351_CR108","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","volume":"27","author":"K Tsukasaki","year":"2009","unstructured":"Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington Jr W et al. (2009). Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 27: 453\u2013459.","journal-title":"J Clin Oncol"},{"key":"BFonc2009351_CR109","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","volume":"50","author":"T Uchiyama","year":"1977","unstructured":"Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H . (1977). Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50: 481\u2013492.","journal-title":"Blood"},{"key":"BFonc2009351_CR110","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1535-6108(02)00123-X","volume":"2","author":"EW Verschuren","year":"2002","unstructured":"Verschuren EW, Klefstrom J, Evan GI, Jones N . (2002). The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell 2: 229\u2013241.","journal-title":"Cancer Cell"},{"key":"BFonc2009351_CR111","doi-asserted-by":"publisher","first-page":"9536","DOI":"10.1128\/JVI.02636-06","volume":"81","author":"T Vider-Shalit","year":"2007","unstructured":"Vider-Shalit T, Fishbain V, Raffaeli S, Louzoun Y . (2007). Phase-dependent immune evasion of herpesviruses. J Virol 81: 9536\u20139545.","journal-title":"J Virol"},{"key":"BFonc2009351_CR112","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nm1087","volume":"10","author":"B Vogelstein","year":"2004","unstructured":"Vogelstein B, Kinzler KW . (2004). Cancer genes and the pathways they control. Nat Med 10: 789\u2013799.","journal-title":"Nat Med"},{"key":"BFonc2009351_CR113","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S1470-2045(08)70338-3","volume":"10","author":"PK Vogt","year":"2009","unstructured":"Vogt PK . (2009). A humble chicken virus that changed biology and medicine. Lancet Oncol 10: 96.","journal-title":"Lancet Oncol"},{"key":"BFonc2009351_CR114","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/343555a0","volume":"343","author":"J Wang","year":"1990","unstructured":"Wang J, Chenivesse X, Henglein B, Brechot C . (1990). Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 343: 555\u2013557.","journal-title":"Nature"},{"key":"BFonc2009351_CR115","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0092-8674(00)81897-8","volume":"88","author":"RA Weinberg","year":"1997","unstructured":"Weinberg RA . (1997). The cat and mouse games that genes, viruses, and cells play. Cell 88: 573\u2013575.","journal-title":"Cell"},{"key":"BFonc2009351_CR116","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/sj.cr.7290372","volume":"15","author":"C Wood","year":"2005","unstructured":"Wood C, Harrington Jr W . (2005). AIDS and associated malignancies. Cell Res 15: 947\u2013952.","journal-title":"Cell Res"},{"key":"BFonc2009351_CR117","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.virol.2007.09.040","volume":"371","author":"J Xie","year":"2008","unstructured":"Xie J, Ajibade AO, Ye F, Kuhne K, Gao SJ . (2008). Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK\/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways. Virology 371: 139\u2013154.","journal-title":"Virology"},{"key":"BFonc2009351_CR118","doi-asserted-by":"publisher","first-page":"9905","DOI":"10.1128\/JVI.01004-06","volume":"80","author":"Y Xu","year":"2006","unstructured":"Xu Y, Rodriguez-Huete A, Pari GS . (2006). Evaluation of the lytic origins of replication of Kaposi's sarcoma-associated virus\/human herpesvirus 8 in the context of the viral genome. J Virol 80: 9905\u20139909.","journal-title":"J Virol"},{"key":"BFonc2009351_CR119","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1084\/jem.191.3.445","volume":"191","author":"TY Yang","year":"2000","unstructured":"Yang TY, Chen SC, Leach MW, Manfra D, Homey B, Wiekowski M et al. (2000). Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 191: 445\u2013454.","journal-title":"J Exp Med"},{"key":"BFonc2009351_CR120","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev.immunol.19.1.475","volume":"19","author":"M Yoshida","year":"2001","unstructured":"Yoshida M . (2001). Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 19: 475\u2013496.","journal-title":"Annu Rev Immunol"},{"key":"BFonc2009351_CR121","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrc1452","volume":"4","author":"LS Young","year":"2004","unstructured":"Young LS, Rickinson AB . (2004). Epstein-Barr virus: 40 years on. Nat Rev Cancer 4: 757\u2013768.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2009351_CR122","doi-asserted-by":"publisher","first-page":"6641","DOI":"10.1073\/pnas.93.13.6641","volume":"93","author":"W Zhong","year":"1996","unstructured":"Zhong W, Wang H, Herndier B, Ganem D . (1996). Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci USA 93: 6641\u20136646.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009351_CR123","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","volume":"384","author":"H zur Hausen","year":"2009","unstructured":"zur Hausen H . (2009). Papillomaviruses in the causation of human cancers \u2014 a brief historical account. Virology 384: 260\u2013265.","journal-title":"Virology"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2009351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2009351","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2009351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T19:24:51Z","timestamp":1685215491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2009351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":123,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["BFonc2009351"],"URL":"https:\/\/doi.org\/10.1038\/onc.2009.351","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"3 December 2009","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}